Thurston, Springer, Miller, Herd & Titak, Inc. Inotiv, Inc. Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $730 Million
- Q2 2025
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Inotiv, Inc. stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 177,725 shares of NOTV stock, worth $373,222. This represents 0.04% of its overall portfolio holdings.
Number of Shares
177,725
Previous 122,167
45.48%
Holding current value
$373,222
Previous $262,000
23.28%
% of portfolio
0.04%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding NOTV
# of Institutions
79Shares Held
8.2MCall Options Held
312KPut Options Held
136K-
Vanguard Group Inc Valley Forge, PA1.29MShares$2.71 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.27MShares$2.67 Million0.0% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1MShares$2.11 Million0.06% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny353KShares$741,6730.0% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$706,7460.27% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $53.7M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...